“Throughout FY20, the company spent $2.62 million on R&D, making it eligible for a rebate of...
Biotech Daily
Proteomics to raise $4 million to $6 million in its initial public offer at 20 cents a share, to list on the ASX and expand its existing protein analysis-based business.